Hosted on MSN16d
Windtree Therapeutics Highlights Istaroxime’s Promise for Cardiogenic Shock
Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...
clinicaladvisor.com8d
Cardiogenic Shock Team in Texas Specialty Hospital Cuts Time to Diagnosis by Half
Nursing staff interventions regarding shock team activation significantly improved the time of diagnosis and acceptance of patients with cardiogenic shock. A cardiovascular specialty hospital in north ...
Yahoo Finance19d
Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
Dr. Alexandre Mebazaa is Professor of Medicine at Université Paris Cité (France), Chair of Department of Anesthesia & Critical Care and an expert in heart failure and cardiogenic shock.